How do I explain the Gleason score to a patient with prostate cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Explaining the Gleason Score to Patients with Prostate Cancer

The Gleason score is a grading system that helps determine how aggressive your prostate cancer is by examining the appearance of cancer cells under a microscope, with scores ranging from 6-10 where higher numbers indicate more aggressive cancer that may require more intensive treatment. 1

What is the Gleason Score?

The Gleason score consists of two numbers that are added together:

  • It represents the sum of the two most common patterns of cancer cell growth seen in your prostate tissue sample 1, 2
  • Each pattern is graded from 1-5 based on how abnormal the cells look compared to normal prostate tissue
  • The first number is the most common pattern, and the second is the next most common pattern
  • These two numbers are added together to give a score between 6-10 (scores of 2-5 are rarely used in clinical practice) 1

What the Numbers Mean

  • Gleason 6 (3+3): Low-grade cancer that typically grows slowly
  • Gleason 7: Intermediate-grade cancer
    • 3+4=7: Less aggressive form of intermediate-grade cancer
    • 4+3=7: More aggressive form of intermediate-grade cancer 1
  • Gleason 8-10: High-grade cancer that may grow and spread more quickly 1

The Grade Group System

To make the Gleason score easier to understand, doctors now often use the Grade Group system (also called ISUP Grade) 1:

Grade Group Gleason Score What it Means
1 6 or less Least aggressive
2 3+4=7 Mildly aggressive
3 4+3=7 Moderately aggressive
4 8 More aggressive
5 9-10 Most aggressive

How the Gleason Score Affects Treatment Decisions

Your Gleason score helps your doctor determine your risk category and treatment options 1:

  • Low-risk disease (Gleason ≤6, Grade Group 1):

    • For life expectancy <10 years: Active surveillance is often recommended
    • For life expectancy ≥10 years: Options include active surveillance, surgery, or radiation therapy
  • Intermediate-risk disease (Gleason 7, Grade Groups 2-3):

    • Treatment typically includes surgery or radiation therapy, sometimes with short-term hormone therapy
    • The difference between 3+4 and 4+3 matters - the latter has a worse prognosis
  • High-risk disease (Gleason 8-10, Grade Groups 4-5):

    • More aggressive treatment is usually recommended, including surgery or radiation with longer-term hormone therapy

Important Points to Remember

  • The order of the numbers matters: 4+3=7 indicates more aggressive cancer than 3+4=7 1
  • Recent research shows that there are meaningful differences even within the same Grade Group - for example, Gleason 8 cancers may behave differently than Gleason 9-10 cancers 3
  • The Gleason score is just one factor in your overall risk assessment, along with PSA level and clinical stage 1, 2
  • Studies show that many patients have difficulty understanding the Gleason system despite its importance in treatment decisions 4

Common Questions

  • "What does my Gleason score mean for my prognosis?" Higher scores correlate with increased risk of disease progression, metastasis, and mortality 1

  • "Why is my Gleason score important?" It helps predict how your cancer might behave and guides treatment recommendations 1, 2

  • "Can my Gleason score change?" Sometimes the score from a biopsy may differ from what's found after surgery, as biopsies sample only portions of the prostate 5

Remember that while the Gleason score is important, it's just one part of your overall cancer assessment. Your doctor will consider this along with other factors to recommend the most appropriate treatment for your specific situation.

References

Guideline

Prostate Cancer Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Gleason grading and prognostic factors in carcinoma of the prostate.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2004

Research

Prostate Cancer Patients' Understanding of the Gleason Scoring System: Implications for Shared Decision-Making.

Journal of cancer education : the official journal of the American Association for Cancer Education, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.